Go to the profile of TIM MULLER, CBO CROSSJECT and Founder SCIENTEX

TIM MULLER, CBO CROSSJECT and Founder SCIENTEX

Pharmaceuticals, private equity, transition management, Crossject = needle free self injectable drugs
  • Crossject = needle free self injectable drugs
  • Members
TIM MULLER, CBO CROSSJECT and Founder SCIENTEX does not have a profile on BioPharma Dealmakers
Why not check out some people that do?